Liver Diseases  >>  Genasense (oblimersen)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Genasense (oblimersen) / Genta
NCT00047229: Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Completed
2
27
Canada
oblimersen sodium, doxorubicin hydrochloride
University Health Network, Toronto, National Cancer Institute (NCI)
Liver Cancer
01/09
04/09

Download Options